Canadian Securities ExchangeThe Daily Bell
CSE Issuer Stories

Seed Capital: Early Investment in Canadian Medical Marijuana Industry Continues to Grow

By Hamish Khamisa

June 13, 20142 min read

If you’re a Canadian investor, the chances are good that you’ve heard or seen a massive spike in interest in medical marijuana.

From pundits to producers and all points in between, interest in the Canadian medical marijuana space has reached frenzied levels, driven there by the new Marihuana for Medical Purposes Regulations (MMPR) announced by Health Canada.

Recent reports peg the number of companies that have applied for licenses from Health Canada to grow and distribute medical grade marijuana at almost 850 with more coming in daily. And while there may only be 13 producers that are licensed to sell or provide medical marihuana under the MMPR today, that number is almost surely expected to rise as those applications work their way through the approval process.

With regulatory, administrative and legal hurdles to the MMPR still remaining, speculators and investors are betting that the entrepreneurs behind many of these firms find a way to stand out and succeed.

SL_logoTwo such entrepreneurial medical marijuana focused companies: Supreme Pharmaceuticals (CSE:SL) and Cannabis Technologies (CSE:CAN) were recently profiled in a pair of pieces by Proactive Investors.

From the piece on Supreme Pharmaceuticals, scale appears to be their strategy of choice. With formal final approval under the MMPR still pending, Supreme Pharmaceuticals is nonetheless continuing to work towards its goals of becoming a premier high volume producer in the near term.

CAN_logoOn a slightly different note, technology appears to be the strategy employed by Cannabis Technologies. With a view towards finding innovative ways to deploy and deliver medicinal cannabis, Cannabis Technologies has its eye on adopting a pharmaceutical company-like model.

With much of the Canadian medical marijuana industry still in flux, it remains to be seen how the marketplace will react to the sheer number of names and providers focused on the space. On the Canadian Securities Exchange, there are a number of companies in addition to Supreme Pharmaceuticals and Cannabis Technologies that are active in the medical marijuana space.

One thing that does remain clear, however, is that interest from speculative capital is still providing attention and dollars to the medical marijuana story.

Keep Reading

Read the blog

Apr 22, 2026CSE Issuer Stories

Rare Earth and Niobium Exploration Moves Forward in Nebraska and British Columbia With Eye on Domestic Supply Chains

While the problem has been widely recognized for decades, many of the world’s leading economies seem only now to be taking seriously the need for control over their access to critical minerals for use in everything from high-tech products to military equipment. If there is a positive side to this, it is that strong markets…

Apex Critical Metals Corp. (CSE:APXC)

Apr 15, 2026CSE Issuer Stories

A Project With Parallels to One of Africa’s Largest Gold Mines Leverages Positive Change in the DRC

The Democratic Republic of the Congo (DRC) has long been viewed as a frontier mining jurisdiction, one characterized by both high risk and high reward, though also one often misunderstood by international investors. Drawing on years of experience with mining in the DRC, Avanti Gold (CSE:AGC; OTCQB:AVTGF) Acting Chief Executive Officer Mohamed Cisse understands the…

Avanti Gold Corp. (CSE:AGC)

Apr 8, 2026CSE Issuer Stories

Strategic Asset Combination Positions Rising Junior to Take Advantage of a Strong Metals Market

When Canadian Copper (CSE:CCI) first set its sights on New Brunswick’s Bathurst Mining Camp, the goal was to acquire prospective ground and move quickly to unlock the opportunity beneath the surface. Home to one of the world’s richest volcanogenic massive sulphide (VMS) districts and the legendary Brunswick No. 12 mine, the region also offers a…

Canadian Copper Inc. (CSE:CCI)